@article{98a6ddf9d83d443dbd650a6e7aecd255,
title = "Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75",
keywords = "Caspase 3/metabolism, Prostatic Neoplasms/genetics, Cathepsin B/antagonists \& inhibitors, Humans, Intercellular Signaling Peptides and Proteins/genetics, Immunoblotting, Male, Cell Survival/drug effects, Cell Cycle/drug effects, Dose-Response Relationship, Drug, Lysosomes/drug effects, Antineoplastic Agents/pharmacology, Flow Cytometry, Transfection, Time Factors, Amino Acid Chloromethyl Ketones/pharmacology, Enzyme Activation/drug effects, TNF-Related Apoptosis-Inducing Ligand/metabolism, Apoptosis/drug effects, Docetaxel, Taxoids/pharmacology, Caspase Inhibitors, Cysteine Proteinase Inhibitors/pharmacology, Membrane Potential, Mitochondrial/drug effects, Caspases/metabolism, Caspase 2/metabolism, Cell Line, Tumor",
author = "Melanie Mediavilla-Varela and Pacheco, \{Fabio J.\} and Frankis Almaguel and Jossymar Perez and Eva Sahakian and Daniels, \{Tracy R.\} and Leoh, \{Lai S.\} and Amelia Padilla and Wall, \{Nathan R.\} and Lilly, \{Michael B.\} and \{De Leon\}, Marino and Casiano, \{Carlos A.\}",
note = "Funding Information: This work was supported in part by NIH awards 5P20MD001632 (CAC, NRW, and MDL), 5R25GM60507 (MDL, CAC, FA, and MMV), 1F31CA117742-01A1 (MMV and CAC), and CDMRP Prostate Cancer Program Award W81XWH-04-1-0087 (MBL).",
year = "2009",
month = aug,
day = "28",
doi = "10.1186/1476-4598-8-68",
language = "English",
volume = "8",
pages = "68",
journal = "Molecular Cancer",
issn = "1476-4598",
}